ICYMI, this week we had stories on the genetics of acne, FDA warnings, and more.
Researchers at the University of California in San Diego have discovered extrafollicular skin cells that transform into antimicrobial fat cells and fight acne, according to a study published in Science Translational Medicine.
Specific genetic variations could be key in identifying acne risk far before the signs arise.
This week's edition of the Mainstream Patients features stories about the benefits of rice water for hair, when skin care expires, and more.
The addition of bempegaldesleukin to nivolumab did not significantly improve progression-free survival, objective response rate, or overall survival vs nivolumab alone in the frontline treatment of patients with unresectable or metastatic melanoma, missing the primary end points of the phase 3 PIVOT IO-001 trial.
Work schedule and location are also important factors.
On March 14, the FDA released a warning for both consumers and health care providers against the use of the Renuvion/J-Plasma device (Apyx Medical) for dermal resurfacing or skin contraction.
Almirall announced today that it will work with the University of Michigan to better understand disease drivers in hidradenitis suppurativa.
In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Jen Hamilton, a TikTok creator who recently made the decision to go the dermatologist to talk about tackling her acne.
Concluding their focused discussion on JAK inhibitors in atopic dermatitis, panelists share advice on the optimal selection based on route of administration and use of these agents.
A recent study examined the possibility of using an mRNA vaccine to prevent the development of skin cancer.
A recent study examined if the neutrophil–lymphocyte ratio (NLR) is a useful inflammatory biomarker in skin cancer prognostication.
A recent study examined the role of inflammation and psoriasis in cardiometabolic diseases, focusing on metabolic syndrome and its components.
In a recent study from the Journal of the American Academy of Dermatology, investigators assessed symptoms, disease burden, and use of analgesics in patients with or without psoriatic arthritis.
State agencies hope to move patients to marketplace.
A phase 1 study of davoceticept and pembrolizumab for advanced malignancies received a partial clinical hold from the FDA following a patient death.
Zoe Diana Draelos, MD, sits down with Dermatology Times® to discuss her new book, Cosmetic Dermatology: Procedures and Practice, which will be releasing in the United States in April of 2022.
The results of physician trials led by the AAFP Innovation Lab are very promising.
Official death toll is almost 6 million, but excess deaths indicate far more may have died from COVID than reported.
Medical groups warn of sweeping ramifications if Congress follows recommendation
A recent study examined the main reasons why patients in the United States seek care from dermatologists.